Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
10.98
+0.13 (1.20%)
At close: Jul 11, 2025, 4:00 PM
11.06
+0.08 (0.73%)
After-hours: Jul 11, 2025, 7:59 PM EDT
Cogent Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
205
Market Cap
1.53B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
COGT News
- 2 days ago - Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 3 days ago - Cogent: Positive Data In NonAdvSM Bodes Well For 2nd Half AdvSM Treatment Results - Seeking Alpha
- 4 days ago - Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock - GlobeNewsWire
- 4 days ago - Cogent Biosciences Announces Proposed $150 Million Public Offering of Common Stock - GlobeNewsWire
- 6 days ago - Why Is Cogent Biosciences Stock Trading Higher On Monday? - Benzinga
- 6 days ago - Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis - GlobeNewsWire
- 4 weeks ago - Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing - GlobeNewsWire
- 6 weeks ago - Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference - GlobeNewsWire